Ọ dị mma maka ndị na-ere ahịa; Ngwongwo maka Ahuma ahia nke ala
Ihe ngwongwo nke ngwongwo na-egbochi ya na-akpọ "patent cliff" site na ndị na-ahụ maka ụlọ ọrụ, nọgidere na-aga 2016. Mkpụrụ ọgwụ nke na-emepụta $ 133 na US ahịa naanị ga-enwe mkparịta ụka dị iche iche, dị ka Evaluate Pharma. Ụfọdụ n'ime ọgwụ ndị kachasị mma na akụkọ ihe mere eme na-echebe nchedo patent na 2011 na 2012. Ọgwụ ọjọọ dịka Lipitor, Plavix na Viagra nwetara ọtụtụ ijeri maka ndị ha na-akwado ha mgbe ha na-edeba ihe ndekọ mgbasa ozi ụwa.
Ọgwụ Ọjọọ na-akwụsị-Patent 2013-2016
Ọgwụ ndị a ma ama na-eme atụmatụ ịkwụsị nchebe ahịa United States n'etiti 2013 na 2016:
2013
- Oxycontin (oxycodone HCI), opioid maka nchịkwa ihe mgbu, natara ahịa $ 2.8 na 2011 maka onye ọrụ US, Purdue Pharma LP.
- AcipHex (rabeprazole sodium), maka ọrịa nrekasị obi na ọrịa acid reflux, onye ọrụ mmepụta: Eisai Inc. na Janssen Pharmaceuticals, Inc.
- Iji ọgwụ zometa (zoledronic acid) bụ ọgwụgwọ maka hypercalcemia nke malignancy kpatara nnukwu ọbara calcium na-akpata ọrịa cancer; $ 1.5 ijeri ahịa zuru ụwa ọnụ na 2010. Ọ bụ Novartis rụpụtara.
- Xeloda (capecitabine) bụ ọgwụgwọ chemotherapy nke oralii maka colorectal metastatic na ọrịa ara ure nke Genentech / Roche mere. Ndị ahịa US na-eto eto site na ọnụọgụ abụọ kwa afọ iji ruo $ 647.6 nde na 2011.
- Opana ER (HCI oxymorphone), agonist opioid kwadoro maka nchịkwa nke oke ụra na nnukwu mgbu, nke Endo Pharmaceuticals Inc. rụrụ na 2011 bụ $ 384.7 nde.
- Asacol (mesalamine), maka ọgwụgwọ nke ọrịa ulcerative colitis, nwetara $ 800 nde zuru ụwa ọnụ na 2010. Manufacturer: Warner Chilcott
2014
- Nexium (esomeprazole) maka ọgwụgwọ ọrịa gwọọ ọrịa gastroesophage (GERD) bụ nke AstraZeneca rụrụ. Ọnụ ahịa ụwa dị na 2010 bụ ijeri $ 4.9.
- Cymbalta (Lloloxetine HCI), nke Eli Lilly mere, bụ maka ịgwọ ịda mbà n'obi, nsogbu nchịkọta ọnụ, ọrịa ọnya na-arịa ọrịa shuga, fibromyalgia na mgbu obi na-adịghị ala ala. Ọnụ ahịa ụwa karịrị $ 4 ijeri 2011.
- Celebrex (celecoxib) bụ maka ọgwụgwọ osteoarthritis na mgbaàmà ogbu na nkwonkwo nke ọrịa obi na njikwa nke nnukwu ihe mgbu ndị okenye. Pfizer, onye na-emepụta ya, na-ere ahịa nke $ 2.5 na 2011.
- Ihe atụ (budesonide / formoterol fumarate dihydrate) maka ụkwara ume ọkụ na COPD bụ nke AstraZeneca rụrụ. Ahịa nke Symbicort bụ pasent $ 3.1 na 2011.
- Lunesta (eszopiclone), ọgwụgwọ maka ehighị ụra nke ọma, bụ Sunovion Pharmaceuticals Inc., nke ụbụrụ nke Dainippon Sumitomo Pharma Co. Ltd. na-ere. Taa ahịa dị na 2010 bụ $ 631 nde.
- Nkwụsịtụ (cyclosporine ophthalmic emulsion) maka ịmalite ịmịpụta ihe na ndị ọrịa na-adịghị ala ala, bụ nke Allergan mere. Na 2010, ahịa zuru ụwa ọnụ ruru $ 621 nde.
- Evista (HCI ụra), nke Eli Lilly rụrụ, bụ maka ịgwọ na igbochi osteoporosis. Evista nwetara $ 1.3 n'ahịa zuru ụwa ọnụ na 2010.
- LAR Sandostatin (octreotide acetate) maka Novartis, bụ maka ọgwụgwọ ọrịa acromegaly, ọrịa mgbaàmà, na ọnya afọ ọsịsa na mgbatị na-arịa ọrịa cancer metastatic. Ọnụ ahịa zuru ụwa ọnụ bụ $ 1.3 na 2010.
- Actonel (risedronate) bụ maka igbochi na ọgwụgwọ osteoporosis. Na 2010, ahịa zuru ụwa ọnụ dị $ 1.6 ijeri. Onye ọrụ Warner Chilcott na-arụ ọrụ nke Actonel.
2015
- Abilify (aripiprazole) site Otsuka Pharmaceutical bụ ọgwụ mgbochi na-eji ọgwụgwọ nke ọrịa schizophrenia na bipolar. N'afọ 2010, ahịa zuru ụwa ọnụ ruru $ 4.6.
- Copaxone (ọgwụ ogwu acetate glatiramer) bụ ọgwụgwọ maka nlọghachite-na-enye ọtụtụ sclerosis (RRMS) nke Teva Pharmaceuticals mere. Ahịa ruru $ 3.57 na 2011.
- Gleevec (imatinib mesylate) bụ ọgwụgwọ maka ọrịa leukemia myeloid na-adịghị ala ala (CML) na ụbụrụ stromal gastrointestinal (GIST). Ọnụ ahịa zuru ụwa ọnụ bụ pasent $ 4.26 na 2010. Gleevec bụ Novartis rụrụ.
- Ndekọ (HCI na-echeta) bụ ọgwụgwọ maka ọrịa Alzheimer siri ike nke Forest Laboratories, Inc. mepụtara.
- Ntuzi (modafinil), ọgwụgwọ maka ụra buru oke ibu na ịmalite ịrịa ọrịa ụra ọrụ, bụ Teva Pharmaceuticals. Ngwaahịa ahụ nyere $ 350 nde ahịa na 2011.
- Ndị na-ebute (albuterol na ipratropium inhalation) bụ njikwa maka ọrịa ndị na-egbochi ọrịa mgbagwoju anya (COPD). Boehringer Ingelheim kwuru na ahịa nke $ 965 na 2010.
- Zyvox (linezolid) bụ ihe ngwọta nke Pfizer mere. Ụlọ ọrụ ahụ kwusara ihe dị ka nde $ 325 n'afọ ụwa niile.
- Prezista (darunavir) bụ onye na - egbochi protease maka ọrịa mmadụ na - egbochi nje virus (HIV). N'ịbụ ndị Janssen Therapeutics kesara, ahịa ahịa Prezista bụ $ 888 nde n'ụwa nile na 2010.
- Avodart (dutasteride) bụ ọgwụgwọ maka hyperplasia prostate na-abaghị uru (gbasaa prostate gland). GlaxoSmithKline kwuru na ọ bụ ihe dị ka nde dollar 973 gburugburu ụwa 2010.
2016
- Crestor (calvaum rosuvastatin) site Astra Zeneca, bụ ọgwụgwọ maka iweda LDL cholesterol m ọbara. Ngwongwo ndi ozo bu ugbua ijeri isii n'ime afo 2010.
- Benicar (olmesartan medoxomil) maka ọbara mgbali elu Daiichi Sankyo, Inc. mere. N'afọ 2010, ahịa dị $ 2.5.
- Cubicin (daptomycin) bụ ọgwụ nje nke Cubist Pharmaceuticals mere. Ngwá ọgwụ ahụ ruru nde $ 644 n'ahịa zuru ụwa ọnụ na 2010. A kwadoro ọgwụ ọjọọ, datomyucin, July 6, 2016.
- Zetia (ezetimibe) ji emeso cholesterol dị elu, nke Merck mere.
- Nuvigil (armodafinil) na - eme ihe banyere ọgwụ ụra metụtara metụtara narcolepsey na ehi ụra. Nke Teva mepụtara.
- Intuniv (guanfacine hydrochloride) eji emeso ADHD nwata, nke Shire mere.
- Seroquel XR (oge fumarate) ji mee ihe maka nnukwu ọgwụgwọ nke mbido ịda mbà n'obi, nke AstraZeneca mere.
N'ezie, e nwere ọtụtụ ihe nwere ike ịhie mgbe otu ụlọ ọrụ na-agba mbọ ịmalite ngwaahịa ọhụrụ n'ime ụlọ ahịa asọmpi.
Isi ihe
EvaluatePharma Ltd. Ụlọ ọrụ nkwado ọgwụ maka ihe ndekọ patent Expiries, EvaluatePharma data na-ekpughe. February 2, 2011.
IMS Health
Ụlọ ọrụ na-akọ